Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis.

Pender, Michael P; Csurhes, Peter A; Smith, Corey; Douglas, Nanette L; Neller, Michelle A; Matthews, Katherine K; Beagley, Leone; Rehan, Sweera; Crooks, Pauline; Hopkins, Tracey J; Blum, Stefan; Green, Kerryn A; Ioannides, Zara A; Swayne, Andrew; Aftab, Blake T; Hooper, Kaye D; Burrows, Scott R; Thompson, Kate M; Coulthard, Alan; Khanna, Rajiv

Pender, Michael P; Csurhes, Peter A; Smith, Corey; Douglas, Nanette L; Neller, Michelle A; Matthews, Katherine K; Beagley, Leone; Rehan, Sweera; Crooks, Pauline; Hopkins, Tracey J; Blum, Stefan; Green, Kerryn A; Ioannides, Zara A; Swayne, Andrew; Aftab, Blake T; Hooper, Kaye D; Burrows, Scott R; Thompson, Kate M; Coulthard, Alan; Khanna, Rajiv.

JCI Insight ; 5(20)2020 10 15.

Article in En | MEDLINE | ID: mdl-33055421

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605530
https://dx.doi.org/10.1172/jci.insight.144624

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JCI Insight Year: 2020 Document type: Article

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605530
https://dx.doi.org/10.1172/jci.insight.144624

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JCI Insight Year: 2020 Document type: Article